[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Thyagaraju, 2017 - Google Patents

Human Beta Defensin-3 Levels in Gingival Crevicular Fluid in Periodontal Health and Disease with and Without Type 2 Diabetes Mellitus

Thyagaraju, 2017

Document ID
270022646969476340
Author
Thyagaraju K
Publication year
Publication venue
PQDT-Global

External Links

Snippet

Background & Objectives: Periodontitis is a complex disease in which disease expression involves intricate interactions of the biofilm with the host immuno inflammatory response and subsequent alterations in bone and connective tissue homeostasis. Diabetes mellitus (DM) …
Continue reading at search.proquest.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N-C(=NH)-NH2), isourea (N=C(OH)-NH2), isothiourea (-N=C(SH)-NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Similar Documents

Publication Publication Date Title
Montreekachon et al. Involvement of P2X7 purinergic receptor and MEK1/2 in interleukin‐8 up‐regulation by LL‐37 in human gingival fibroblasts
Vieira Ribeiro et al. Cytokines and bone‐related factors in systemically healthy patients with chronic periodontitis and patients with type 2 diabetes and chronic periodontitis
Türkoğlu et al. Gingival crevicular fluid levels of cathelicidin LL‐37 and interleukin‐18 in patients with chronic periodontitis
Vernal et al. Levels of interleukin‐17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis
Aral et al. Differential expression of inflammasome regulatory transcripts in periodontal disease
Güncü et al. Salivary antimicrobial peptides in early detection of periodontitis
Gamonal et al. Delayed neutrophil apoptosis in chronic periodontitis patients
Gomes et al. Defensins in the oral cavity: distribution and biological role
Yılmaz et al. Overexpressions of hBD-2, hBD-3, and hCAP18/LL-37 in gingiva of diabetics with periodontitis
Pereira et al. Influence of periodontal status and periodontopathogens on levels of oral human β‐defensin‐2 in saliva
Nędzi-Góra et al. The immune response in periodontal tissues
Takeuchi et al. Salivary levels of antibacterial peptide (LL‐37/hCAP‐18) and cotinine in patients with chronic periodontitis
Dommisch et al. Antimicrobial responses of primary gingival cells to Porphyromonas gingivalis
Ertugrul et al. Gingival crevicular fluid levels of human beta‐defensin‐2 and cathelicidin in smoker and non‐smoker patients: a cross‐sectional study
Yong et al. Periodontopathogens and human β‐defensin‐2 expression in gingival crevicular fluid from patients with periodontal disease in Guangxi, China
Özdemir et al. Gingival tissue human beta‐defensin levels in relation to infection and inflammation
JP2015051000A (en) Method for modulating cell surface receptors for preventing or reducing inflammation
Türkoğlu et al. Antimicrobial peptide hCAP‐18/LL‐37 protein and mRNA expressions in different periodontal diseases
Costa et al. Gingival crevicular fluid levels of human beta‐defensin 1 in individuals with and without chronic periodontitis
Pereira et al. Gingival crevicular fluid levels of human beta-defensin 2 and 3 in healthy and diseased sites of individuals with and without periodontitis
Cloitre et al. IL-36γ is a pivotal inflammatory player in periodontitis-associated bone loss
Rudick et al. Triggering receptor expressed on myeloid cells in the pathogenesis of periodontitis: potential novel treatment strategies
Dabija-Wolter et al. Limited in-depth invasion of Fusobacterium nucleatum into in vitro reconstructed human gingiva
Dolińska et al. The effect of nonsurgical periodontal therapy on HNP1-3 level in gingival crevicular fluid of chronic periodontitis patients
Guo et al. Associations of salivary BPIFA1 protein in chronic periodontitis patients with type 2 diabetes mellitus